Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes.
Bancroft T, DeBuysscher BL, Weidle C, Schwartz A, Wall A, Gray MD, Feng J, Steach HR, Fitzpatrick KS, Gewe MM, Skog PD, Doyle-Cooper C, Ota T, Strong RK, Nemazee D, Pancera M, Stamatatos L, McGuire AT, Taylor JJ. Bancroft T, et al. J Exp Med. 2019 Oct 7;216(10):2331-2347. doi: 10.1084/jem.20190164. Epub 2019 Jul 25. J Exp Med. 2019. PMID: 31345930 Free PMC article. Clinical Trial.
Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Krugliak Cleveland N, et al. Among authors: bancroft t. BMC Gastroenterol. 2024 Sep 17;24(1):314. doi: 10.1186/s12876-024-03378-6. BMC Gastroenterol. 2024. PMID: 39289603 Free PMC article.
Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017-2020 influenza seasons.
McGovern I, Chastek B, Bancroft T, Webb N, Imran M, Pelton SI, Haag MDM. McGovern I, et al. Among authors: bancroft t. Int J Infect Dis. 2024 Sep;146:107160. doi: 10.1016/j.ijid.2024.107160. Epub 2024 Jul 3. Int J Infect Dis. 2024. PMID: 38969330 Free article.
Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting.
Russell-Smith A, Murphy L, Nguyen A, Blauer-Peterson C, Terpenning M, Cao F, Li S, Bancroft T, Webb N, Dorman S, Shah R. Russell-Smith A, et al. Among authors: bancroft t. J Comp Eff Res. 2024 Feb;13(2):e230142. doi: 10.57264/cer-2023-0142. Epub 2023 Dec 15. J Comp Eff Res. 2024. PMID: 38099517 Free PMC article.
88 results